Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2022 09:55 ET | Source: hC Bioscience, Inc

hC Bioscience Announces Extension of Series A to $40 Million

Expansion of syndicate enables broadening of platforms, expansion of pipeline and extension of runway Lead platform centered on engineered tRNAs for human diseases caused by premature termination...
September 13, 2022 10:17 ET | Source: hC Bioscience, Inc

hC Bioscience Appoints Brad Margus to its Board of Directors

CAMBRIDGE, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- hC Bioscience, Inc., a company developing first-in-class tRNA-based therapeutics targeting protein dysfunction in genetically defined diseases,...
September 06, 2022 10:17 ET | Source: hC Bioscience, Inc

hC Bioscience Expands Leadership and Research & Development Teams

CAMBRIDGE, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- hC Bioscience, Inc., a biotech company developing first-in-class tRNA-based therapeutics targeting protein dysfunction in genetically defined...
February 23, 2022 10:17 ET | Source: hC Bioscience, Inc

hC Bioscience Announces $24 Million Series A Financing to Develop Innovative Pipeline of Protein-Editing Therapies

Combining a strong syndicate of investors, seasoned management, and exemplary scientific advisorshC Bioscience is developing a new class of therapy for genetically defined diseases based on more than...